Stockholders approve warrant and share issuance under securities purchase agreement

Envoy Medical, Inc.

At special meeting on Nov 26, 2025, stockholders approved issuance of warrants and related Class A common stock to comply with Nasdaq Listing Rule 5635(d).
Votes: 13,599,174 for, 243,009 against, 5,700 broker non-votes on the issuance proposal.
Adjournment proposal also approved (13,345,775 for) but not used.
Approval clears way for closing of securities purchase agreement dated Sep 22, 2025 with unnamed purchasers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.